Factually! with Adam Conover

Does Pfizer Have Too Much Power? with Hannah Kuchler

Dec 22, 2021

56:55

Highlights

AI Chapters

Episode notes

Is There Still Interest in Drug Pricing?

02:56

How Do We Parse Out Them From Them?

01:40

Are You Taking Out a Second Mortgage on the Old Military Base?

02:21

Introduction

4min

Are You Sceptical About the Vaccines?

3min

Is Fiser's Roll in the Pandamic?

3min

Is Enfrirna a Vaccine?

2min

Is There a Pandemic Coming?

2min

Is It the Fiser Vaccine?

2min

Pandemic Vaccines - What a Great Offer!

3min

Is Fiser Still Trying to Milk This Sit Ton a Lot?

2min

Is There a Flip Side to This?

4min

10.

The Cost of the Vaccine Is Not the Issue

2min

11.

Vaccines in Nigeria

2min

12.

Are We Giving This Much Power to Our Company?

4min

13.

Is the Government Really Solvent?

2min

14.

Are You Taking Out a Second Mortgage on the Old Military Base?

2min

15.

Is There a Gun Held at These Countries Heads?

2min

16.

Feiser's Cove 19 Booster Shot Offers Protection From Omicron Variant

2min

17.

The Science Is Solid, and I Don't Think It Is Cynical.

2min

18.

Is It a Vaccine, a Booster, or a Vaccine?

2min

19.

How Do We Parse Out Them From Them?

2min

20.

The Pandemic and the Pharmaceutical Industry

3min

21.

Is There Still Interest in Drug Pricing?

3min

22.

What Can Our Electorate Leaders Be Doing Now?

4min

23.

The Pandemic

3min

Even though the COVID-19 vaccines were born of publicly-funded research, our privatized medical system has left them to for-profit companies like Pfizer to distribute, giving these private companies massive power in a time of great need. On the show this week to dive into the ways Pfizer has used and abuse its power is Financial Times global pharmaceutical correspondent Hannah Kuchler. Learn more about your ad choices. Visit megaphone.fm/adchoices See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.